Self-assembled proteomimetics: Synthetic antibodies that are easier and cheaper to produce

For decades, lab-made antibodies have been used to support patients fighting specific diseases. These treatments have become a cornerstone of cancer therapy and were among the first medical solutions developed to combat COVID-19. However, producing antibodies in the lab is costly and time-consuming.

This article was originally published here